Sun Pharma initiates a Class II recall o
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Warning letters, 483s, Recalls, Import Alerts, Audit observations
</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)
In May 2023, Sun Pharma initiated recall of two lots of antidepressant drug Bupropion Hydrochloride
USFDA has granted full approval for Pfizers Paxlovid, first Oral antiviral for COVID; This is
FDA has approved Xacduro injection (Durlobactam, a new molecular entity in combination with sulbactam) for
